Due to their unique properties, engineered nanoparticles (NPs) have found broad use in industry, technology, and medicine, including as a vehicle for drug delivery. However, the understanding of NPs' interaction with different types of mammalian cells lags significantly behind their increasing adoption in drug delivery. In this study, we show unique responses of human epithelial breast cells when exposed to polymeric Eudragit â RS NPs (ENPs) for 1-3 days. Cells displayed dose-dependent increases in metabolic activity and growth, but lower proliferation rates, than control cells, as evidenced in tetrazolium salt (WST-1) and 5-bromo-2′-deoxyuridine (BrdU) assays, respectively. Those effects did not affect cell death or mitochondrial fragmentation. We attribute the increase in metabolic activity and growth of cells culture with ENPs to three factors: (1) high affinity of proteins present in the serum for ENPs, (2) adhesion of ENPs to cells, and (3) activation of proliferation and growth pathways. The proteins and genes responsible for stimulating cell adhesion and growth were identified by mass spectrometry and Microarray analyses. We demonstrate a novel property of ENPs, which act to increase cell metabolic activity and growth and organize epithelial cells in the epithelium as determined by Microarray analysis.
Introduction
The size, penetrative, carrier, and other properties of nanoparticles (NPs) allow them to enter the human body through inhalation, digestion, injection, and skin contact (Oberdorster et al. 2005; Rivera-Gil et al. 2012) . Within the body, NPs can be transported to organs, tissues, and cells far from the site of exposure, where NPs cross anatomical barriers and penetrate live cells and their organelles (Rivera-Gil et al. 2012) . The nanoparticulated forms of drugs and growth factors have potential to increase bioavailability, stability, and action of those agents while at the same time decrease toxicity and delivery variability associated with dosimetry (Santamaria 2012) . Accordingly, among the diverse potential uses of NPs are their potential for targeted effects, including chemotherapy (Waite and Roth 2012) .
However, because the interactions between unloaded NPs and different types of mammalian cells are poorly understood we undertook this investigation.
Eudragit â RS NPs (ENPs) are a nonbiodegradable, positively charged copolymer (Eidi et al. 2010) , and have been used for per os administration of drugs such as ibuprofen, cyclosporine, and indomethacin (Pignatello et al. 2002; Bhardwaj et al. 2010; Eidi et al. 2012) . Recent work by Eidi et al. (2012) on the effect of unloaded ENPs on rat macrophages caused concern among researchers when results showed cytotoxic effects that included apoptosis, autophagy, and possible mitochondrial fragmentation. Concerns over toxicity of NP treatment emerged when studies demonstrated that some engineered NPs, including carbon nanotubes, titanium dioxide, and aluminum oxide, caused inflammatory responses in rat lungs. Similarly, carbon fullerenes have been shown to cause lipid peroxidation in the brain and gills of largemouth bass (Oberdorster 2001 (Oberdorster , 2004 Warheit et al. 2004; Santamaria 2012) , and polyacrylate ester, one component of ENPs, was shown to cause pleural effusion, pulmonary fibrosis, and granuloma in humans (Song et al. 2009 ). Hence, in retrospect the effect of ENPs on macrophages in Eidi et al. may not be surprising because macrophages are designed to induce phagocytosis of living as well as inert materials, such as ENPs. Despite the expected behavior of macrophages, the study of Eidi et al. showed the need for further research to clarify the effect of unloaded ENPs on the growth of different types of cells before attempting drug delivery to cells, tissues, and organisms. The few studies that have been performed with Eudragit or its constitutive polymers have produced contradictory results on its effect on cell growth. Eudragit RL stimulated the growth of fibroblasts (Boag and Sefton 1987) , while Eudragit RS 100 slowed the growth of hepatocytes while activating their differentiation (Hamamoto et al. 1998) . The constitutive polymers of Eudragit, poly(methylmethacrylate)-poly(methacrylic acid) copolymer, displayed no effect on the viability of neural cells (Dekeyser et al. 2008) . However, none of the above studies used ENPs, nor did they report the effect of ENPs on cell metabolic activity or the growth of epithelial cells.
Given uncertainties about the effect of NPs, in general, and ENPs in particular, the goal of our study was to evaluate the effect of unloaded ENPs on the metabolic activity, growth, and proliferation of epithelial cells in culture. A range of 3-200 lg/mL of ENPs for 2000 cells per well of a 96-well plate was selected to compare our data to the data of Eidi et al., who used a similar range of ENP concentration. The use of different amounts of ENPs is important in our study, because it reflects the possibility of various actual direct and indirect exposure levels.
Materials and Methods

Preparation of ENPs
The Eudragit â RS 100 copolymer used in this study was purchased from Evonik Industries (Essen, Germany) , and is a copolymer of ethylacrylate and methylmethacrylate, with low methacrylic acid ester content with quaternary ammonium groups. ENPs were prepared as described previously (Eidi et al. 2010) L-glutamine, and 0.25% penicillin-streptomycin) but containing WST-1 (Cell Proliferation Reagent, Roche, Germany) was added and cells were incubated for 1-5 h. The 96-well plates were then read by spectrophotometry at 450 nm.
BrdU and EdU cell proliferation assays
Cells were seeded in 96-well plates at 2000 per well and grown in a tissue culture incubator at 37°C and 5% CO 2 for 24 h in the presence of ENPs in 200 lL of their respective media. 5-bromo-2′-deoxyuridine (BrdU) was used to label proliferating cells with a BrdU cell proliferation assay (Calbiochem, Darmstadt, Germany) . Cells were incubated with BrdU for 6 h, then fixed with fixing/denaturing solution. The BrdU-labeled DNA was detected with a BrdU Mouse mAb kit using the manufacturer's protocol. The absorbance in each plate was measured using a spectrophotometer at dual wavelengths of 450-540 nm. To quantify the percentage of proliferating cells and total cell count after 24 h, HMEC 184 cells were seeded (5000 per chamber) in an eight-chamber slide (Lab-tek, PA) and treated with 0, 6, 25, and 100 lg/mL ENPs (Carlsbad, CA) for 24 h. Cells were incubated with 5-ethynyl-2′-deoxyuridine (EdU) (30 lmol/L) from Invitrogen (Carlsbad, CA) for 6 h, and then washed twice with PBS and fixed with 4% paraformaldehyde. Cells were permeabilized with 0.1% Triton-X 100 in PBS for 5 min, then incubated with 5% normal donkey serum-blocking buffer for 2 h. Incorporated EdU was detected with a copper-catalyzed fluorescent azide reaction (Click-iT; Invitrogen), after which slides were washed with PBS and mounted on cover slips with mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI) (Vector, Burlingame, CA). Nuclei and EdU-positive nuclei were counted using the (209/0.8 NA) air objective of an Axio Observer.Z1 fluorescence microscope (Zeiss, Germany) with Metamorph software (Molecular Devices, CA).
Confocal laser scanning microscopy
ENPs were conjugated with Nile red (nominal diameter = 73 nm, zeta potential = +47, and polydispersity index = 0.34) according to a method described previously 
Total protein measurement and immunoblots
Cells were washed twice with PBS and then solubilized with 5% NP-40. Total protein concentration was determined using a BCA protein assay kit (Pierce Biotechnology, Radford, IL). Western blotting was performed as previously described (Hussien and Brooks 2011) . Primary antibodies used were rabbit anti-cytochrome oxidase subunit IV, mouse anti-b-actin, and mouse anti-voltagedependent anion channel (VDAC) (Abcam, Cambridge, MA). Band intensity was quantified as previously described (Hussien and Brooks 2011) .
Purification and identification of serum proteins coated on ENPs with proteomic mass spectrometry A mixture of serum and ENPs was centrifuged at 2500g for 10 min and the obtained pellet was washed twice with PBS and exposed to organic extraction with dichloromethane. The organic phase was examined on thin layer chromatography (TLC), and the aqueous phase was examined with UV/VIS spectrometry. To identify the proteins attached to ENPs, FBS (5.9 mL,~21.44 mg of proteins) containing 780 lg/mL of ENPs was centrifuged at 10,000g for 3.5 min. 
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. A total of 69 proteins were cited only by their B. taurus name and were not included in data analysis because either (i) their relative abundance (RA) was very low (1-10), (ii) their identified peptides span less than 3% of the protein sequence, or (iii) they were isoforms of, or closely related to, already analyzed proteins. Proteins were ranked according to their (i) abundance (A), namely the ratio of spectrum count/length, and (ii) sequence coverage (SC), namely the percentage of the entire sequence that was expressed in the peptides found in trypsin hydrolysate. The RA was calculated as the ratio of the most abundant protein to the least abundant protein. The InterPro domains (http://www.ebi.ac.uk/interpro/) of 178 proteins were retrieved and were submitted to the STRING database (http://string-db.org/).
Total RNA extraction and microarray analysis
Total RNA was extracted from HMEC 184 cells (50% and 90% confluence) incubated with 25 lg/mL ENPs for 24 h, and without incubation (control). The quality of RNA extracted with RiboPure kit (Ambion, Austin, TX) was determined with spectrophotometry and capillary electrophoresis, using RNA 6000 Nano â (Agilent 2100 Bioanalyser TM , Santa Clara, CA). cDNA synthesis, cRNA synthesis, Cy3-dye labeling, and microarray hybridization were carried out using 100 ng of total RNA according to manufacturer protocol (One-Color Microarray-Based Gene Expression Analysis, version 6.6). Microarray slides (SurePrint G3 Human GE v2 8x60K, Agilent technologies) were scanned with an Agilent DNA microarray scanner. The acquisition, quantification of array images, and primary data analysis were performed using Agilent Feature Extraction Software. Data were first normalized with quantile method and stringent filtering criteria were next used to identify genes whose expression level was significantly changed, with a modified Student's t-test (P ≤ 0.001) and FC (fold change) ≥2.0. FC of mean of three replicates (for each ENP exposure and cell condition) on control were calculated. The selected genes display acceptable false discovery rate (<15%) according to Benjamini et al. (2001) . The Database for Annotation, Visualization, and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov) was then used to analyze and extract (i) relevant GO terms (http:// godatabase.org), (ii) functions and expression data on Genecard (http://www.genecards.org), and (iii) known and predicted protein-protein interactions (http://string-db. org) for selected genes (da ). The raw data of our microarrays are available on http://www.ncbi.nlm. nih.gov/geo/, using the GSE45598, GSE45868, and GSE45869 access numbers.
Statistical analysis
Testing for significant differences between groups at P < 0.05 was done either by the Student's t-test, one-way analysis of variance (ANOVA) with Tukey's post test (comparing all groups), or Dunnett's post test (comparing all groups vs. control) using RLPlot or Prism software.
Results
Dose-dependent increases in metabolic activity of epithelial cells exposed to ENPs
Human mammary epithelial cells (HMEC 184) (~40% confluent) exposed to ENPs from 3.1 to 200 lg/mL for 24, 48, and 72 h showed a dose-dependent increase in metabolic activity, as measured by the WST-1 assay (Fig. 1A-C) . The increase in WST-1 indicates an increase in the activity of mitochondrial succinate dehydrogenase (Mosmann 1983) . Using HMEC 184 confluent cells (~90% confluent), ENPs induced a dose-dependent increase in metabolic activity (data not shown). Two human epithelial breast cancer cell lines (MCF-7 and MDA-MB-231) grown in different media were also incubated with varying doses of ENPs for 24 h; again, results showed a dose-dependent increase in metabolic activity ( Fig. 1D and E) . In a separate experiment, ENPs were mixed with culture media (3.1 to 200 lg/mL) and added to 96-well plates, either 24 h before seeding the HMEC 184 cells or at the same time as cell seeding, and a WST-1 assay was performed 2 days later. A similar trend of dose-dependent increased metabolic activity was seen in both cases (Fig. A1) . Because a false-negative toxicity has been reported previously with 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide-formazan in interacting with NPs, but not with the WST-1 assay (Worle-Knirsch et al. 2006) , additional control cells were subjected to WST-1 to rule out the possibility of reagent interaction with ENPs (Fig. 1F) .
Dose-dependent decrease in cell proliferation and cell count of epithelial cells exposed to ENPs
A dose-dependent decrease in cell proliferation, measured with a BrdU enzyme-linked immunosorbent assay (ELISA), was observed in the HMEC 184 cells after 24 h incubation with ENPs ( Fig. 2A) . The decrease in proliferation was further confirmed with a proliferation assay that quantified proliferating HMEC 184 cells labeled with EdU using a fluorescent azide reaction (Fig. 2B ). An increase in total protein content in the HMEC 184 cells, measured with a BCA assay, was observed after 24 h of incubation with ENPs (Fig. 2C) , and a decrease in total cell count was seen only in those cells incubated with a high dose of ENPs (100 lg/mL), as measured with DAPI stain (Fig. 2D) . Additional control cells were subjected to BrdU assays to rule out the possibility of reagent interaction with ENPs (Fig. 2E) . Neural progenitor cells (NPC) were treated with 0-200 lg/mL ENPs to test whether results were specific to epithelial cells. A similar dose-dependent increase in metabolic activity and dosedependent decrease in cell proliferation were seen in those cells (Fig. A2 ).
ENPs formed a visible network with serum proteins that adhered to cells in culture. ENPs entered the cells and caused an increase in total mitochondrial volume without an increase in mitochondrial biogenesis An opalescent flocculate was visible when ENPs were added to HMEC 184, MDA-MB-231, and MCF-7 culture media. No flocculate was observed with the addition of ENPs to serum-free medium or PBS. Labeling of ENPs with Nile red fluorescent congregated dye and examination with confocal microscopy showed that ENPs entered the cells ( (Fig. 4A ). However, a decrease in Cox4 and VDAC proteins was seen with Western blotting, but neither was a significant change (Fig. 4B ). This implies an increase in cell size without a corresponding increase in mitochondrial biogenesis.
Proteomic MS showed that the ENP-serum protein network contains proteins sharing common InterPro domains and exhibiting protease, antiprotease, epidermal growth factor, adhesion, and binding properties
To identify the nature of the visible flocculate, the pellet generated from centrifugation of a mixture of serum and ENPs was washed twice with PBS and exposed to organic extraction. No lipids were seen in the organic phase on TLC, but the aqueous phase showed a peak at 280 nm and an increased absorbance at 240 nm, with the UV/VIS spectrum suggesting the presence of proteins (data not shown). The pellet was examined with SDS-PAGE and MALDI-TOF MS, which identified 290 nonredundant proteins belonging to B. taurus and nine human cytokeratins. From MALDI-TOF MS, 178 proteins were identified and analyzed. Sequence coverage varied from 79.2% for albumin to 0.4% for titin. The RAs were calculated as the ratio of the most abundant to the least abundant protein, varied between 2581 and 1. Regression analysis at a 95% confidence level showed a linear correlation between protein abundance in MS and the protein concentration in plasma (Fig. A3) . However, notable exceptions were seen later in the InterPro analysis. Because the coefficient of correlation (r) was only 0.66, and because some proteins were present at concentrations less than 1 nmol in plasma (e.g., kininogen-2 isoform II, actins, periostin, and serpinA 3-3), but were abundant in the MS chromatograms, we believe that proteins were not randomly fixed on ENPs according to their abundance in FBS. Therefore, we retrieved the InterPro domains of most of the 178 proteins we analyzed. The most frequently shared InterPro domain was "IPR006210:EGF-like," shared by 18 different proteins (Table 1) . Approximately 120 (70%) of 170 analyzed proteins shared at least two common domains. A high number of proteins belonging to InterPro domains are known to be involved in endopeptidase inhibitor activity, proteolytic activity or its regulation, protein binding, calcium binding, cell adhesion, and signaling, or have certain structural motifs like leucine-rich or immunoglobulin domains (Table 1) . By calculating the mean of RA at the domain level, but not at the entire protein level, we found that proteins were coated not only due to their relative amounts in FBS but also due to their affinities for ENPs, reflecting their composition in domains rather than the structure of the entire protein (Table 1A) . When submitting 178 genes to the STRING database, 169 protein encoding genes were recognized, and more than 80% of these showed interactions, either at evidence, confidence, or action levels. Seemingly, the purified proteins were also isolated by interactions between and among themselves (e.g., by protease inhibitor/protease interactions, or known binding properties of individual proteins). Serpins, proteases, and coagulation factors were found at the central core around which proteins involved in cell adhesion, growth, differentiation, and migration clustered (Fig. A4) . 
Microarray analysis for HMEC 184 cells treated with 25 lg/mL ENPs showed activation of proliferation and growth pathways
Microarray analysis was performed on HMEC 184 treated cells to identify the pathways induced by ENP treatment. HMEC 184 treated cells indicated 38 and 287 genes (50% and 90% confluence, respectively) whose expression was significantly altered when compared with control. The stringency of transcriptomic analysis was higher in the 90% confluence series (P < 0.001) than the 50% confluence series (P < 0.05). Few genes were downregulated in either cell culture condition: 3 and 4 genes for the 50% and 90% confluence series, respectively.
Several of the upregulated genes were genes involved in pathways of proliferation, growth, and transformation. These genes included PIM-1, which contributes to cell proliferation and survival; VTCN1, which promotes epithelial cell transformation; ADRA1B (upregulated in the 50% confluence dishes, data not shown), which activates mitogenic responses and has been found in normal and cancerous breast cell lines (Vazquez et al. 2006 ); LCN2, described as a gene involved in breast tumor progression (Yang et al. 2012) ; ELF3, an ETS domain transcription factor that is epithelial specific and is known to transactivate alone, or synergistically with other genes also upregulated in our experiment (such as CLND7, FLG, KRT8, SPRR1A, MMP1, MM9, and TGM3), epithelial cell differentiation; and NDRG2, which is involved in WNT signaling pathway (Shimomura et al. 2010; Lorentzen et al. 2011) .
The functional annotation using DAVID revealed GO terms such as epithelial cell differentiation, epidermis development, response to wounding, and ectoderm development with a highly significant probability (P < 10E-12, FC > 10). These GO terms indicate that ENP action caused a spatial organization of breast epithelium (Table 2A ). The effect of ENP on epithelial cell organization was also seen in significant changes within genes involved in apicolateral plasma membrane organization, cell-cell junction, cell-cell adhesion, and apical junction complex organization. These genes included CLDN4, CLDN3, CGN, CLDN7, DSG4, and CDSN.
Differentially expressed genes at a level of P < 10E-03 were detected in breast tissues by Illumina Body Map (Cambridge, UK), indicating a strong relationship in expression pattern between HMEC 184 cell line and human breast tissue. Only nine of 84 genes (~11%) displayed no expression in human breast tissue: IL36RN, IL36G, CDSN, CWH43, ATP12A, NLRP10, IGFL2, KRT34, and MMP1. Eighteen of the upregulated genes were described by Toulza et al. (2007) as upregulated genes in epidermal barrier function: A2ML1, ADAM8, BNIPL, CDSN, CLDN3, CLDN4, CLDN7, DSG4, FLG, IGFL2, KLK6, KRT23, KRT24, KRT34, KRT80, LIPH, SERPINB2, and SPRR1A.
Several genes upregulated in macrophages after exposure to NPs (Eidi et al. 2012) were also upregulated in HMEC 184 cells when exposed to ENPs. These genes were (i) TLR1 and 2, which recognize bacterial proteins or lipopeptides, and are activated by IL8 (IL8 was also upregulated); (ii) MARCO, which binds to Gram (+) and (À) bacteria; and (iii) S100A12, which binds to ANXA1 (both were upregulated), and displays antibacterial activity against Escherichia coli and Pseudomonas aeruginosa. The upregulation of genes such as RAB11FIP1, SPON2, MYO5B, and MAL2 indicates that the presence of ENPs with HMEC 184 cells allows those cells to acquire macrophage functions involved in endocytosis and potentializing MARCO. Some of the induced genes code products that use proteins adsorbed on ENP as substrate, such as MMP8, MMP9, and LCN2, all of which activate procollagenase, and cleave collagene IV and VI, which bind to ENP. MMP9 and SERPINB2 degrade fibronectin and vitronectin, both adsorbed on ENP. KK6 displayed hydrolytic activity against extracellular matrix proteins adsorbed on ENP, such as fibronectin, laminin, vitronectin, and collagen.
Forty-one of the 84 genes in the 90% confluence series recognized by the STRING database (http://string-db.org) were linked at confidence, evidence, or action level (Fig. 5) . Regarding the action level, some relevant AGPAT9 AGPAT9 AGPAT9  LCN2  LCN2 LCN2   SAA3P  SAA3P SAA3P  IGFL2  IGFL2 IGFL2  PLA2G4D PLA2G4D PLA2G4D   IL1RN  IL1RN IL1RN   PCDH1 PCDH1 PCDH1  CWH43  CWH43 CWH43  PRR15L  PRR15L PRR15L  ANXA1 ANXA1 ANXA1  IL8  IL8 IL8  SERPINB2 SERPINB2 SERPINB2   S100P S100P S100P   B3GNT3  B3GNT3 B3GNT3  MMP10  MMP10 MMP10  MMP1 MMP1 MMP1  KRT23 KRT23 KRT23   MMP9  MMP9 MMP9  OVOL1 OVOL1 OVOL1  MARCKSL1  MARCKSL1 MARCKSL1  FA2H FA2H FA2H   FUT2 FUT2 FUT2   FUT3  FUT3 FUT3  MAPRE2  MAPRE2 MAPRE2  TLR2 TLR2 TLR2  OASL OASL OASL  ISG20  ISG20 ISG20   ELF3  ELF3 ELF3  ADAM8  ADAM8 ADAM8  LIPH LIPH LIPH  TLR1  TLR1 TLR1  NDRG2  NDRG2 NDRG2  CLDN4 CLDN4 CLDN4  NCF2  NCF2 NCF2   HOPX HOPX HOPX   RARRES1  RARRES1 RARRES1  CLDN7 CLDN7 CLDN7  PLBD1  PLBD1 PLBD1  CGN CGN CGN  KRT24  KRT24 KRT24   DSG4 DSG4 DSG4   CLDN3  CLDN3 CLDN3  ATP12A  ATP12A ATP12A  GUCY1A3 GUCY1A3 GUCY1A3  S100A12  S100A12 S100A12  MARCO MARCO MARCO   APCDD1 APCDD1 APCDD1  PIM1  PIM1 PIM1  VTCN1 VTCN1 VTCN1  ELOVL4  ELOVL4 ELOVL4  CYP4B1  CYP4B1 CYP4B1  GGT6 GGT6 GGT6   CDSN CDSN CDSN   KLK6  KLK6 KLK6  FLG FLG FLG   SPINK5  SPINK5 SPINK5 S100A7 S100A7 S100A7 catalysis involve: (i) initial activation of proMMP9 by MMP1, (ii) proMMP-9 activation by MMP-10, (iii) CEA-CAM1&6 heterodimer, (iv) MMP9 potentializing IL8, and (v) complex forming of serum amyloid A protein with upregulated TLR genes, SAA1/TLR2/TLR1.
Discussion
We examined the effect of ENPs on metabolic activities and proliferation rates of epithelial in culture. We show here (1) an increase in metabolic activity and growth of epithelial cells after incubation with ENPs, (2) an activation of proliferation and growth genes in epithelial cells treated with ENPs, and (3) an effect of ENPs extracting from media and delivering to cell surfaces specific FBS plasma proteins involved in cell growth and metabolic activity of cells grown in culture. These results are discussed in more detail below.
An increase in the metabolic activity and growth of epithelial cells after incubation with ENPs
Contrary to the results obtained by Eidi et al. (2012) , who showed a cytotoxic effect of unloaded ENPs on macrophages, we show here no cytotoxicity effect of unloaded ENPs; in contrast, we show a dose-dependent increase in the metabolic activity of epithelial cells that was accompanied by a small, but significant dose-dependent decrease in cell proliferation. The overall effect was a small, but significant decrease in the total cell count when compared with ENP-untreated control cells. We attribute the increase in metabolic activity to an increase in cell size and total mitochondrial volume and activity. ENPs or similar products have been used by several groups on many type of cells for different reasons (Boag and Sefton 1987; Broughton and Sefton 1989; Hamamoto et al. 1998; Dekeyser et al. 2008; Eidi et al. 2012) , but outcomes similar to the changes in metabolic activity and cell proliferation rate we found have not been reported. Differences may result from the use of different NPs or cell types by other groups. For example, ENPs used in this study were the same as those used by Eidi et al., so the differences in results are attributable to cell type. Macrophages are naturally designed to induce phagocytosis of inert or living particles, so it is not surprising that ENPs displayed cytotoxic effect on macrophages that were attributable to enhanced NP uptake and macrophage overload. In addition, the ENPs precipitated with FBS plasma proteins in the bottom of the culture dishes after~2 h, which may have reduced the amount of nutrients available for cells in suspension, such as macrophages, and may have increased the amount of nutrients available to adherent cells such as epithelial cells. Further research will be required to understand the contradictory results, but a similar trend was seen when neural stem cells were treated with ENPs, and so the newly described property of ENPs may affect multiple cell types.
An activation of proliferation and growth genes in epithelial cells treated with ENPs
The observed effects of ENPs decreasing cell proliferation rates while increasing metabolic activity (measured with BrdU and WST-1, respectively) were unexpected. The microarray data showed an activation of proliferation and growth pathways in HMEC 184 cells treated with ENPs, but we only found an increase in growth and metabolic activity in those cells. Further research will be required to understand what prevented cell proliferation. It is possible that cells invested energy in metabolism and growth more than in proliferation. However, we saw no significant decrease in proliferation at lower levels of ENP treatment, which means that the lower ENP exposure has a positive effect on cell growth without an associated effect on proliferation. A similar result was obtained by Cui et al. (2012) who used gold NPs (Au NPs). Cui et al. showed that small Au NPs enter HeLa cells and cause a cytotoxic effect, but that large aggregated Au NPs adhere to the cell surface and cause an increase in cell growth. Our data showed that ENPs caused an increase in cell metabolic activity in the three epithelial cells that were tested, the normal (HMEC 184) and the cancerous (MCF-7 and MDA-MB-231) cells. However, our results with the cancerous cells gives cause for concern regarding the use of ENPs as a cancer drug delivery system, because increasing the access of cancer cells to nutrients would be counterproductive even if ENPs targeted those cells and carried cytotoxic substances to them. On the other hand, stimulating growth in cells subjected to targeted chemotherapy could overstress normal cells leading to apoptosis. The effect of ENP treatment in increasing cancer cell metabolic activity has not been reported previously, and further research is needed to address the potentially counter-productive effect of ENP increasing cancer cell activity.
ENP extracts and delivers to cell surfaces specific FBS plasma proteins that are crucial for cell growth and metabolic activity of cells grown in culture At present it is premature to speculate about the mechanisms by which Eudragit RS served to increase metabolism in cells. However, through its dual function of "polyaffinity nanochromatography" (i.e., aggregating numerous factors that promote metabolism and growth) and adherence to cells, Eudragit RS in effect concentrates stimuli for cell growth on cell surfaces.
To date, other NPs, such as magnetic NPs coated with antibodies, ligands, or receptors, have been used to extract proteins from sera and other media (Safarik and Safarikova 2004; Gao et al. 2009 ). Eudragit RS 100 was reported by some teams for the purification of proteins from bacteria and yeast (such as protein A [Kamihira et al. 1992 ], b-glucosidase [Agarwal and Gupta 1996] , and xylanase [Sharma and Gupta 2002] ), the immobilization of enzymes (such as amylosucrase of Nesseira [Wang et al. 2011]) , and in affinity chromatography for monoclonal antibody purification (Taipa et al. 2000) . Eudragit RS 100 was also used by some groups to refold fibroblast growth factor (FGF) and lysozyme (Huang and Leong 2009) . The same proposed mechanism was also reported with TGF-b and KGF-2 ). Interestingly, the proteins extracted by the process described by those groups belong to an InterPro Domain, "TGF-b," that is closely related to the protein TGF-b that refolds well in an Eudragit buffer. Sharma and Gupta (2002) were the first to use the term "macroaffinity," and to link it to use of the Eudragit RS 100 polymer. Following their lead we named our method "polyaffinity nanochromatography." The methods we developed here allow the isolation of proteins that are closely related by structure, activity, and interactions, and that are not randomly distributed. In addition, the protocol we describe may allow the extraction and isolation of a select group of proteins for diagnostic purposes from animal and human fluids (serum, plasma, cerebrospinal fluid, urine, exudates, and transudates), as the proteins described here may also be present in those fluids in physiological or pathological conditions. Hence, the 45 proteins highlighted in were either never described in plasma or are present in plasma in pathological conditions. On the other hand, further research is required if ENPs are to be used increasingly in drug delivery, especially in light of their absorption of many important proteins and growth factors.
Conclusion
Our data show that ENPs can be used to increase the metabolic activity and growth of epithelial cells in a dosedependent manner. The mechanism for this behavior stems from the ability of ENPs to bind to certain proteins in culture media and to bring them closer to the surface of cells. Those proteins are involved in cell adhesion, growth, differentiation, and migration. The observed behaviors of ENPs suggest new uses of ENPs beyond drug coating. A B Figure A1 . Metabolic activity of HMEC 184 cells following 48 h exposure to ENPs. ENPs (lg/mL) were preincubated for 24 h in plates with culture media at different concentrations before cells were seeded and incubated for 48 h (A). Cells were incubated for 48 h with ENPs (lg/ mL) at different concentrations at the same time as cell seeding (B). Groups not sharing the same letter are different at the 95% level according to ANOVA analysis (P < 0.0001, Tukey's honest significant difference). Figure A3 . Linear regression analysis between the logarithm of plasma concentration (nmol) and the logarithm of relative abundance as obtained by mass spectrometry data. Regression analysis at a 95% confidence level showed a linear correlation between protein abundance in mass spectrometry and the concentration in plasma (r = 0.66, P < 0.0001). Figure A4 . Interactions of purified gene products at the action level as retrieved from String. A total of 178 identified genes were submitted to the STRING database (http://string-db.org/). Of these, 169 genes were recognized by the STRING database and more than 80% showed interactions, either at the evidence, confidence, or action level.
